What is the appropriate iron sucrose dosing regimen for a 45‑kg adolescent with iron‑deficiency anemia?

Iron Sucrose Dosing for a 45-kg Adolescent

For a 45-kg adolescent with iron-deficiency anemia, administer iron sucrose 200 mg intravenously per infusion, given 2–3 times weekly, for a total cumulative dose of 600–1200 mg depending on baseline hemoglobin and calculated iron deficit. 1

Standard Dosing Protocol

• Maximum single dose: 200 mg per infusion to minimize dose-related anaphylactoid reactions and adverse events 1, 2
• Infusion frequency: Administer 2–3 times per week until total iron deficit is repleted 1
• Total cumulative dose: Typically 1000–1200 mg during the induction phase, which may require 5–7 visits 1, 2
• Infusion duration: Minimum 30 minutes for a 200 mg dose, diluted in 100 mL of 0.9% normal saline 1, 2

Weight-Based Considerations for Adolescents

• For adolescents weighing ≥50 kg, the adult dosing protocol applies directly 3
• For those <50 kg (including your 45-kg patient), the same 200 mg maximum single dose is appropriate, as pediatric studies have safely used 100–200 mg doses in children and adolescents 4, 5
• No test dose is required for iron sucrose, unlike iron dextran preparations 1, 2

Calculating Total Iron Deficit

The total dose depends on hemoglobin level and body weight:

• For hemoglobin 10–12 g/dL and body weight <70 kg: Approximately 1000 mg total dose 1
• For hemoglobin 7–10 g/dL and body weight <70 kg: Approximately 1500 mg total dose 1
• Since your patient weighs 45 kg, expect to administer 5–7 infusions of 200 mg each to achieve full repletion 2

Administration Guidelines

• Dilution: Mix 200 mg in 100 mL of 0.9% normal saline 2
• Infusion rate: Administer over 30–60 minutes; the FDA allows 15 minutes minimum, but 30 minutes is safer and reduces infusion reactions 2
• Alternative rapid push: For select patients (particularly those with chronic kidney disease), a 2–5 minute IV push is FDA-approved, though this is less commonly used in adolescents without renal disease 2
• No test dose needed: Iron sucrose does not require a test dose unless the patient has a history of IV iron sensitivities or multiple drug allergies 1, 2

Safety Monitoring

• Monitor vital signs during and for at least 30 minutes after each infusion to detect hypotension, flushing, or other infusion reactions 1, 2
• Resuscitation equipment and trained personnel should be immediately available, with IV epinephrine, diphenhydramine, and corticosteroids on hand 2
• Start slowly: Begin the infusion at a slower rate for the first 5 minutes to assess for early reactions 2

Adverse Event Profile

• Overall hypersensitivity rate: Approximately 0.5%, significantly lower than iron dextran 1, 2
• Common mild effects: Hypotension, nausea, vomiting, diarrhea, headache, and dysgeusia 2
• Rare serious reactions: Anaphylaxis is exceedingly rare (<1:200,000 administrations) 1
• Hypophosphatemia: Occurs in only 1% of iron sucrose patients, compared to 58% with ferric carboxymaltose 2
• Pediatric safety data: In 142 pediatric patients, only one developed cough and wheezing during infusion, with no other adverse events reported 5

Contraindications and Precautions

• Absolute contraindication: Active bacteremia or ongoing bloodstream infection 1, 2
• Relative caution: Patients with severe asthma, eczema, mastocytosis, or multiple drug allergies have higher risk of hypersensitivity reactions 2
• Chronic infection alone (without bacteremia) is not an absolute contraindication if risk/benefit favors treatment 2

Follow-Up and Monitoring

• Recheck hemoglobin at 4 weeks after starting therapy to confirm adequate response (expect ≥2 g/dL increase) 1, 2
• Recheck iron studies (ferritin, transferrin saturation) at 4–6 weeks after completing the full course 1
• Target parameters: Ferritin >100 ng/mL and transferrin saturation >20% 1
• Avoid early testing: Do not evaluate iron parameters within the first 4 weeks after administration, as circulating iron can interfere with assay results 1
• Long-term monitoring: Continue monitoring every 3 months for the first year, then every 6 months for 2–3 years to detect recurrent deficiency 2

Practical Example for Your 45-kg Patient

If hemoglobin is 8 g/dL:

• Total iron deficit ≈ 1200 mg 1
• Administer 200 mg IV over 30 minutes, three times per week 1
• Total of 6 infusions over 2 weeks 2
• Recheck hemoglobin at week 4; expect hemoglobin ≥10 g/dL 1

Key Clinical Pitfalls to Avoid

• Do not exceed 200 mg per single dose in adolescents, as higher doses (300–500 mg) are associated with markedly higher adverse reaction rates 2
• Do not administer during active infection, particularly bacteremia 1, 2
• Do not use a test dose routinely, but consider it only in patients with prior IV iron reactions or multiple drug allergies 2
• Do not infuse too rapidly: Slower infusion rates (30–60 minutes) reduce the incidence of complement activation-related pseudo-allergy (CARPA) 2